- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 311/24 - Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atoms of the sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
Patent holdings for IPC class C07C 311/24
Total number of patents in this class: 25
10-year publication summary
|
1
|
0
|
1
|
3
|
5
|
3
|
1
|
0
|
4
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| E. I. du Pont de Nemours and Company | 3452 |
3 |
| The Scripps Research Institute | 1347 |
3 |
| Academic Pharmaceuticals Incorporated | 11 |
2 |
| Baylor College of Medicine | 1014 |
2 |
| Modernatx, Inc. | 1279 |
2 |
| The Texas a & M University System | 1930 |
2 |
| Changchun Genescience Pharmaceutical Co., Ltd. | 156 |
2 |
| Bayer Pharma AG | 1005 |
1 |
| FUJIFILM Corporation | 30774 |
1 |
| DSM IP Assets B.V. | 5395 |
1 |
| Chugai Seiyaku Kabushiki Kaisha | 1434 |
1 |
| Nektar Therapeutics | 401 |
1 |
| N.V. Organon | 523 |
1 |
| Shanghai East Hospital | 8 |
1 |
| Calico Life Sciences LLC | 120 |
1 |
| Persevere Therapeutics Inc. | 5 |
1 |
| Other owners | 0 |